pulmonary fibrosis Archives

Home pulmonary fibrosis

Latest Posts

News and Trends 23 May 2023

Vicore reports new data from idiopathic pulmonary fibrosis study

Vicore Pharma Holding AB (publ), has announced an updated interim analysis of its AIR phase 2a trial with C21 in idiopathic pulmonary fibrosis (IPF). With 51 patients enrolled, the data…

May 23, 2023 - 4 minutesmins - By Jim Cornall

Podcast 14 Apr 2023

Beyond Biotech podcast 41: Sarcoidosis

This week, to coincide with World Sarcoidosis Day, we talk about sarcoidosis with Marcin Szumowski, CEO and president of the management board of Molecure. World Sarcoidosis Day As part of…

April 14, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 9 Jan 2023

Alentis reports positive results from fibrosis study

Alentis Therapeutics has announced positive results from a single ascending dose phase 1 study of its lead program, ALE.F02, currently in development for the treatment of advanced kidney, lung and…

January 9, 2023 - 2 minutesmins - By Jim Cornall

shutterstock idiopathic pulmonary fibrosis

More News! 11 Oct 2022

First patient dosed in study of idiopathic pulmonary fibrosis

Redx, a clinical-stage biotech company, is trialing RXC007, a wholly owned rho associated coiled-coil containing protein kinase 2 (ROCK2) selective inhibitor as a potential treatment for patients with idiopathic pulmonary…

October 11, 2022 - 3 minutesmins - By Liza Laws

Resources

Categories

The latest news on

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering